Journal of Drug Metabolism & Toxicology
Open Access

High Impact List of Articles

• Conference Announcement: Global summit on Industrial and Clinical Toxicology
  Belinda Cridge

  2021 Conference Announcement: Journal of Drug Metabolism & Toxicology

• Treatment of Depression in Patients on Anticoagulation Therapy: Antidepressant-Rivaroxaban Drug Interactions
  Carlos Clayton Tôrres Aguiar

  Short Communication: Journal of Drug Metabolism & Toxicology

• The Effects of N-acetylcysteine in Patients with Amanita phalloides Intoxication
  Ahmet Akin, Sakir Özgür Keskek, Didem Aydin Kiliç, Mehmet Aliustaoğlu and Nedime Şahinoğlu Keşkek

  Research Article: Journal of Drug Metabolism & Toxicology

• Critical Regulation of Calcium Signaling and NMDA-type Glutamate Receptor In Developmental Neural Toxicity
  Cheng Wang

  Review Article: Journal of Drug Metabolism & Toxicology

• Alternative Negative Feedback Control in the Aryl Hydrocarbon Receptor Signaling Pathway
  Jason Matthews

  Editorial: Journal of Drug Metabolism & Toxicology

• The Post-Transcriptional Regulator EIF2S3 and Gender Differences in the Dog: Implications for Drug Development, Drug Efficacy and Safety Profiles
  Tamara J Nicolson, Philip D Glaves and Ruth RA Roberts

  Short Article: Journal of Drug Metabolism & Toxicology

• Metabolism and Toxicity of High Doses of Cyclo (his-pro) Plus Zinc in Healthy Human Subjects
  Koichi Uyemura, Shawkat Dhanani, Dean T Yamaguchi and Moon K Song

  Research Article: Journal of Drug Metabolism & Toxicology

Conference Proceedings

• Targeting resistin signaling pathway as a strategy for enhancing the effect of chemotherapy drugs in reducing breast cancer cells aggressiveness
  Dimiter Avtanski, Beatriz Caraballo and Leonid Poretsky

  Scientific Tracks Abstracts: Journal of Pharmaceutical Care & Health Systems

• Characterization of Verapamil hydrochloride entrapped in poly (lactide-co-glycolide) (PLGA) particles
  Bienvenido S Balotro and Paula Marie Sabban

  Scientific Tracks Abstracts: Journal of Pharmaceutical Care & Health Systems

• SYN-004 (ribaxamase), an orally administered Ã?²-lactamase for prevention of antibiotic-mediated dysbiosis of the gut microbiome and Clostridium difficile infection in patients receiving intravenous Ã?²-lactam antibiot
  John F Kokai-Kun

  Posters & Accepted Abstracts: Journal of Drug Metabolism & Toxicology

• The impact of surface funtionalization in design of targetted drug delivery system
  Heyam Saad

  Scientific Tracks Abstracts: Drug Designing: Open Access

Relevant Topics in Pharmaceutical Sciences